Advanced Filter

Filter by Group

Filter by Market Availability

Did you mean 1400 60 7?
Displaying drugs 2276 - 2300 of 3173 in total
Investigational
Hispidulin (4',5,7-trihydroxy-6-methoxyflavone) is a potent benzodiazepine (BZD) receptor ligand with positive allosteric properties .
Experimental
CTX130 is an allogeneic CRISPR/Cas9-mediated genetically modified CAR T cell therapy targeting CD70 antigen.
Investigational
Barbexaclone, a salt compound of propylhexedrine and phenobarbital, is a potent antiepileptic. By weight, barbexaclone is 40% propylhexedrine and 60% phenobarbital. While barbexaclone has sedative properties, propylhexedrine has psychostimulant properties intended to offset these sedative effects. Pharmacokinetic studies have demonstrated that the pharmacokinetics of phenobarbital given as barbexaclone are not...
Experimental
Matched Description: … By weight, barbexaclone is 40% propylhexedrine and 60% phenobarbital. …
Experimental
Investigational
Vixarelimab is under investigation in clinical trial NCT03816891 (A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Prurigo Nodularis).
Investigational
Investigational
Experimental
Matched Iupac: … 7-ethyl-1,4-dimethylazulene …
Investigational
Investigational
An inhibitor of calcium-dependent isoforms of protein kinase C.[A253002,A253007]
Investigational
Pristimerin is a quinone methide triterpenoid researched for its anti-cancer potential.
Investigational
Investigational
Experimental
Matched Iupac: … (2E,4E,6R)-7-[4-(dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxohepta-2,4-dienamide …
SB-224289 is a small molecule with a high affinity for human 5-HT1B receptors.
Investigational
Displaying drugs 2276 - 2300 of 3173 in total